Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Nov 22 LLY Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22 HALO Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
Nov 22 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
Nov 22 VKTX Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
Nov 22 VKTX Viking Therapeutics a new buy at B Riley on lead obesity asset VK2735
Nov 22 HALO Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Nov 22 HALO Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal
Nov 22 VKTX VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
Nov 22 LLY VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
Nov 22 LLY Investing in Pharma Stocks? Check These 3 Things First
Nov 22 HALO Halozyme withdraws $2.1 billion buyout offer for Evotec
Nov 22 HALO Halozyme gains after withdrawing Evotec bid
Nov 22 HALO Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
Nov 22 VKTX RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
Nov 22 LLY Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Nov 22 LLY Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
Nov 22 HALO Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
Nov 22 MODD Modular Medical drops 8%, prices $8.2M stock offering
Nov 22 MODD Modular Medical Announces Pricing of $8.2 Million Public Offering
Nov 21 MODD Modular Medical announces proposed public offering
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags